StonvexLoading…
StonvexSide-by-side peer comparison: valuation, growth, margin, and Activity Index.
Theme: biotech · 9 peers
Best-in-column highlighted in green, worst in red. Sorted by Activity Index.
| Rank | Ticker | Price | Day | Mkt Cap | P/E | P/S | Rev YoY | Gross M. | Activity Index |
|---|---|---|---|---|---|---|---|---|---|
| You | EXAS Exact Sciences | — | — | — | — | — | — | — | 50 |
| 1 | LLY Eli Lilly | $1006.70 | +0.00% | — | — | — | — | — | 55 |
| 2 |
Fundamentals via Finnhub (TTM). Quotes near real-time. Activity Index is Stonvex's proprietary momentum/sentiment composite, not investment advice.
| $45.48 |
| +0.00% |
| — |
| — |
| — |
| — |
| — |
| 52 |
| 3 | AMGN Amgen | $336.23 | +0.00% | — | — | — | — | — | 52 |
| 4 | NVO Novo Nordisk | $45.80 | +0.00% | — | — | — | — | — | 50 |
| 5 | MRNA Moderna | $50.03 | +0.00% | — | — | — | — | — | 50 |
| 6 | BNTX BioNTech | $91.99 | +0.00% | — | — | — | — | — | 50 |
| 7 | REGN Regeneron | $712.87 | +0.00% | — | — | — | — | — | 50 |
| 8 | VRTX Vertex Pharma | $450.41 | +0.00% | — | — | — | — | — | 50 |
| 9 | GILD Gilead Sciences | $132.06 | +0.00% | — | — | — | — | — | 50 |